8 unknown. 8 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Unknown 8 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow CBD: new trials by email Literature Review of CBD trials Research Report on CBD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hippocampal Response to Acute Oral Doses of CBD During an fMRI Memory Task CBD, Placebo - CBD | Phase 1 / Phase 2 | Unknown | Hartford Hospital | 20 | 2021-12-15 | 2024-04-12 |
| Cannabidiol for Prevention of Chemotherapy-induced Peripheral Neuropathy Cannabidiol 100 MG/ML - Chemotherapy-induced Peripheral Neuropathy | Phase 2 | Unknown | Zealand University Hospital | 54 | 2021-03-03 | 2022-02-08 |
| Using Cannabidiol to Treat Diabetic Peripheral Neuropathy of the Feet CBD, Placebo - Diabetic Peripheral Neuropathic Pain | Phase 2 | Unknown | Pure Green | 50 | 2020-12-10 | 2021-02-02 |
| CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms Cannabidiol, PLACEBO - SARS-CoV2 | Phase 2 / Phase 3 | Unknown | University of Sao Paulo | 100 | 2020-07-06 | 2021-09-28 |
| Cannabis Oil for Chronic Non-Cancer Pain Treatment CBD, CBD+THC, Placebo - Chronic Non-cancer Pain | Phase 2 | Unknown | Hamilton Health Sciences Corporation | 309 | 2019-01-01 | 2018-11-13 |
| An Open Label Study of Multiple Doses of Cannabidiol in the Prevention of Acute Graft-Versus-Host Disease (GVHD) CBD - Prevention aGVHD | Phase 2 | Unknown | Kalytera Therapeutics Israel, Ltd. | 36 | 2018-06-12 | 2021-09-01 |
| Extended Use of Cannabidiol for the Prevention of Graft-versus-host-disease Cannabidiol, cyclosporine, Methotrexate - Graft vs Host Disease | Phase 2 | Unknown | Rabin Medical Center | 10 | 2015-07-01 | 2015-06-23 |
| Cannabidiol (CBD) for the Management of Cannabis Withdrawal: A Phase II Proof of Concept Study CBD - Cannabis Use Disorder | Phase 2 | Unknown | The University of New South Wales | 5 | 2014-03-01 | 2014-03-11 |
Graft vs Host Disease (1) · Marijuana Abuse (1) · Peripheral Nervous System Diseases (1)
Hamilton Health Sciences Corporation (1) · Hartford Hospital (1) · Kalytera Therapeutics Israel, Ltd. (1) · Pure Green (1) · Rabin Medical Center (1) · The University of New South Wales (1) · University of Sao Paulo (1) · Zealand University Hospital (1)
United States (2) · Australia (1) · Brazil (1) · Canada (1) · Denmark (1) · Israel (1)
Debra Kimless, M.D. (1) · Godfrey Pearlson, MD (1) · Martin Weltman, PhD MD (1) · Sebastian W Nielsen, MD (1)